Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Tiered approaches to chromatographic bioanalytical method performance evaluation: recommendation for best practices and harmonization from the Global Bioanalysis Consortium harmonization team.

Lowes S, Hucker R, Jemal M, Marini JC, Rezende VM, Shoup R, Singhal P, Timmerman P, Yoneyama T, Weng N, Zimmer D.

AAPS J. 2015 Jan;17(1):17-23. doi: 10.1208/s12248-014-9656-x. Epub 2014 Oct 23.

2.

Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays.

Rezende VM, Rivellis A, Novaes MM, de Alencar Fisher Chamone D, Bendit I.

Drug Des Devel Ther. 2013 Aug 5;7:699-710. doi: 10.2147/DDDT.S42902. eCollection 2013.

3.

Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance.

Rezende VM, Rivellis AJ, Gomes MM, Dörr FA, Novaes MM, Nardinelli L, Costa AL, Chamone DA, Bendit I.

Rev Bras Hematol Hemoter. 2013;35(2):103-8. doi: 10.5581/1516-8484.20130030.

4.

The role of soluble fiber intake in patients under highly effective lipid-lowering therapy.

Ramos SC, Fonseca FA, Kasmas SH, Moreira FT, Helfenstein T, Borges NC, Moreno RA, Rezende VM, Silva FC, Izar MC.

Nutr J. 2011 Aug 2;10:80. doi: 10.1186/1475-2891-10-80.

5.

Predicting smear negative pulmonary tuberculosis with classification trees and logistic regression: a cross-sectional study.

Mello FC, Bastos LG, Soares SL, Rezende VM, Conde MB, Chaisson RE, Kritski AL, Ruffino-Netto A, Werneck GL.

BMC Public Health. 2006 Feb 23;6:43.

Supplemental Content

Loading ...
Support Center